Business · 22/05/2018
FDA Requests Public Comment on Proposed Collection of Information Related to Generic Drug Development
The Food and Drug Administration is seeking public input on a proposed collection of information related to generic drug development, as required by the Paperwork Reduction Act of 1995, and will accept comments for 60 days.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →